MTHFR polymorphisms in relation to ovarian cancer risk.
OBJECTIVE
Folate has been hypothesized to influence carcinogenesis due to its dual role in DNA methylation, which regulates gene expression, and synthesis of purine and thymidylate, which is vital for DNA repair. Thus, we examined ovarian cancer risk in relation to two functional polymorphisms (C677T and A1298C) in the MTHFR gene.


METHODS
We genotyped the C677T (rs1801133) and A1298C (rs1801131) MTHFR polymorphisms in 1642 cases and 2068 controls from three studies, the New England Case Control Study (NEC), Nurses' Health Study (NHS), and Mayo Clinic Ovarian Cancer Case Control Study (MAY).


RESULTS
Overall, we observed no association between either SNP and ovarian cancer risk (pooled C677T p(trend)=0.59 and A1298C p(trend)=0.58). Significant associations (C677T p(trend)=0.001, A1298C p(trend)=0.02) between these MTHFR SNPs and serous ovarian cancer risk were observed in the NEC study, but were not replicated in the NHS and MAY studies.


CONCLUSIONS
MTHFR SNPs C677T and A1298C are not associated with ovarian cancer risk. Our results highlight the need for validation of genetic findings.
Terry
Kathryn L
KL
Ob-Gyn Epidemiology Center, Brigham and Women's Hospital, Boston, MA 02115, USA. kterry@partners.org
Tworoger
Shelley S
SS
Goode
Ellen L
EL
Gates
Margaret A
MA
Titus-Ernstoff
Linda
L
Kelemen
Linda E
LE
Sellers
Thomas A
TA
Hankinson
Susan E
SE
Cramer
Daniel W
DW
D000328:Adult; D016022:Case-Control Studies; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000201:enzymology / Q000453:epidemiology / Q000235:genetics* / Q000401:mortality; D020641:Polymorphism, Single Nucleotide; D014481:United States / Q000453:epidemiology
D042965:Methylenetetrahydrofolate Reductase (NADPH2)
Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1611-21
12496052
J Natl Cancer Inst. 2004 Mar 17;96(6):434-42
15026468
Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):281-7
17301261
Genet Med. 2002 Mar-Apr;4(2):45-61
11882781
Clin Cancer Res. 2005 Mar 1;11(5):2047-52
15756031
Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1198-203
15894672
Nat Genet. 2001 Nov;29(3):306-9
11600885
Eur J Cancer. 2000 Dec;36(18):2313-6
11094304
Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):397-404
18268124
Eur J Cancer Prev. 2006 Dec;15(6):511-5
17106331
Breast Cancer Res Treat. 2007 Sep;104(3):299-308
17063264
Cancer. 1996 Mar 1;77(5):917-23
8608484
Pharmacogenetics. 2002 Jun;12(4):339-42
12042673
Am J Epidemiol. 2006 Jun 15;163(12):1101-11
16554344
J Natl Cancer Inst. 2000 Jul 19;92(14):1151-8
10904088
J Nutr. 1999 Sep;129(9):1656-61
10460200
Br J Nutr. 2000 Jun;83(6):593-6
10911766
Cancer Res. 1997 Mar 15;57(6):1098-102
9067278
Eur J Cancer. 2009 May;45(8):1443-9
19223177
Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):89-100
20056627
Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):505-12
12050090
Am J Epidemiol. 1994 Dec 1;140(11):1016-9
7985649
Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1753-9
17855693
Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5606-11
11929966
Cancer Epidemiol Biomarkers Prev. 1999 Sep;8(9):825-9
10498402
Am J Epidemiol. 1984 May;119(5):837-9
6720679
J Natl Cancer Inst. 2004 Mar 3;96(5):396-402
14996861
Cancer Causes Control. 2004 Dec;15(10):1085-93
15801492
J Natl Cancer Inst. 1993 Jun 2;85(11):875-84
8492316
Cancer Epidemiol Biomarkers Prev. 1995 Sep;4(6):649-54
8547832
Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1781-9
18628432
JAMA. 1999 May 5;281(17):1632-7
10235158
Nat Genet. 2009 Sep;41(9):996-1000
19648919
Semin Oncol. 1992 Apr;19(2 Suppl 4):46-50
1532459
J Mol Med (Berl). 2001 Sep;79(9):522-8
11692165
Ann Oncol. 2001 Nov;12(11):1589-93
11822759
Anticancer Res. 1997 Sep-Oct;17(5A):3671-4
9413221
Int J Cancer. 2002 Dec 10;102(5):545-7
12432561
Epidemiology. 2001 Jul;12(4):420-8
11416780
Am J Hum Genet. 1998 May;62(5):1044-51
9545395
Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1331-6
15298954
Clin Cancer Res. 2003 May;9(5):1611-5
12738713
J Nutr. 2003 Jun;133(6):1937-42
12771342
Nat Genet. 1995 May;10(1):111-3
7647779
Lancet. 2003 Mar 8;361(9360):865-72
12642066
Cancer Res. 2008 Apr 1;68(7):2498-506
18381459
Thromb Haemost. 1997 Jul;78(1):523-6
9198208
Am J Epidemiol. 2005 Mar 1;161(5):442-51
15718480
Epidemiology. 1998 May;9(3):350-4
9583430
Mol Genet Metab. 1998 Jul;64(3):169-72
9719624
Cancer Causes Control. 2000 Dec;11(10):965-74
11142531
Cancer Res. 1996 Nov 1;56(21):4862-4
8895734
Int J Cancer. 2007 Nov 15;121(10):2225-32
17471564
Clin Cancer Res. 2010 Feb 1;16(3):995-1007
20103664
Cancer Detect Prev. 2005;29(2):146-54
15829374
Breast Cancer Res Treat. 2007 Dec;106(2):263-71
17260091
Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):285-92
14973104
Carcinogenesis. 1997 Dec;18(12):2307-11
9450474
Breast Cancer Res Treat. 2010 Sep;123(2):549-55
20143151